13. In order to reduce the risk of errors, the Institute for Safe Medication Practices (ISMP) recommends that medications with similar-looking names and packaging should be:

Answer: D

Explanation:

Medications with similar-looking names and packaging should be physically separated on the pharmacy shelves.

To reduce the risk of errors, it is essential that medications with similar names and packaging are physically separated on pharmacy shelves. This practice helps to minimize confusion and ensures that healthcare providers can easily distinguish between these products.

A) stored only in automated dispensing machines

Storing medications only in automated dispensing machines may enhance safety; however, it does not directly address the issue of similar-looking names and packaging. This option does not ensure that the medications are visually distinct when accessed, which is crucial in reducing errors.

B) removed from the pharmacy formulary

While removing certain medications from the pharmacy formulary could potentially reduce errors, it is not a practical solution for all cases. This action could limit patient access to necessary medications and does not address the problem of similar packaging and naming for those that remain.

C) filled by a pharmacist, not a pharmacy technician

Assigning the task of filling these medications solely to pharmacists may seem beneficial; however, it does not alleviate the confusion caused by similar-looking names and packaging. Both pharmacists and technicians are trained to handle medications, and this option does not provide a proactive solution to the visual similarity issue.

D) physically separated on the pharmacy shelves

Physically separating medications with similar names and packaging is the most effective strategy to prevent mix-ups. This approach allows for clearer visual distinction and reduces the likelihood of errors during the dispensing process.

Conclusion

Physically separating medications with similar names and packaging is a critical safety measure that directly addresses the risk of errors. The other options either do not provide a sufficient solution to the problem or introduce new challenges, making option D the most effective and practical choice in ensuring medication safety.